The National Institute of Nursing Research established its updated research framework to support its 2022–2026 strategic plan and mission of leading “nursing research to solve pressing health challenges and inform practice and policy-optimizing health and advancing health equity.” The framework focuses on and encourages research that “informs practice and policy and improves health and quality of life for all people, their families and communities, and the society in which they live.”
Maintaining a patient’s personal grooming during an inpatient stay is an important aspect of holistic nursing care, but nurses and hospitals alike may fall short when it comes to textured hair care, nurses reported in the American Journal of Nursing.
Marking her first year at the National Cancer Institute (NCI), Katrina Goddard, PhD, director of the NCI’s Division of Cancer Control and Population Sciences, outlined a foundation of future research for DCCPS, priority research areas, and the impact of research on diverse populations in a December 2022 interview.
Direct-to-consumer genomic testing is a patient-initiated type of testing that is marketed to the general public in advertisements on all media. The tests can be purchased online or in stores without requiring a healthcare professional order or third-party payer authorization. Customers send a saliva sample to the company and view their test results on a secure website, but the results are not included in their electronic health record unless they specifically request it.
Almost 11.5 million people signed up for healthcare insurance on HealthCare.gov from November 1–December 15, 2022, President Joe Biden announced in December 2022. Enrollment increased 18% over the same period in 2021.
In the final days of 2022, as the world turned the calendar to celebrate a new year, the cancer advocacy community also celebrated: One of ONS’s longtime priority bills, the Lymphedema Treatment Act, achieved a landmark legislative win, passing the U.S. Senate as part of the fiscal year 2023 omnibus funding package. President Biden signed it into law on December 29, 2022, securing access to treatment supplies for patients with cancer-related lymphedema.
Patients with suspected hematologic cancers complete the bone marrow biopsy processes and begin treatment more than one month sooner when the procedures are shifted from interventional radiology to a dedicated, nurse-led bone marrow biopsy clinic, researchers reported in a poster presentation at the Association of VA Hematology/Oncology meeting.
Danya Garner, PhD, RN, NPD-BC, OCN®, CCRN-K, associate director of continuing professional education at The University of Texas MD Anderson Cancer Center in Houston, will serve as the next Oncology Nursing Society president. During its November 2022 meeting, the ONS Board of Directors appointed Garner to succeed Jeannine Brant, PhD, APRN-CNS, AOCN®, FAAN, who concludes her three-year board tenure at ONS’s 48th Annual Congress® in San Antonio, TX.
None of the patients who were admitted for an immune checkpoint inhibitor–related toxicity but received structured teaching at discharge were subsequently readmitted within 30 days, compared to nearly 50% of patients who did not receive teaching, ONS member Michelle L. Rohlfs, DNP, APRN, FNP-BC, AOCNP®, reported in study findings published in the Clinical Journal of Oncology Nursing.
On February 9, 2023, the U.S. Food and Drug Administration approved dostarlimab-gxly (Jemperli®) for adult patients with mismatch repair deficient recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that has progressed on or following a prior platinum-containing regimen in any setting and are not candidates for curative surgery or radiation.